These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3772338)

  • 1. A proposed model to explain persistent infection of host cells with Coxiella burnetii.
    Roman MJ; Coriz PD; Baca OG
    J Gen Microbiol; 1986 May; 132(5):1415-22. PubMed ID: 3772338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii.
    Baca OG; Scott TO; Akporiaye ET; DeBlassie R; Crissman HA
    Infect Immun; 1985 Feb; 47(2):366-9. PubMed ID: 3967922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional reconstruction of Coxiella burnetii-infected L929 cells by high-voltage electron microscopy.
    Hechemy KE; McKee M; Marko M; Samsonoff WA; Roman M; Baca O
    Infect Immun; 1993 Oct; 61(10):4485-8. PubMed ID: 8406840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of DNA, RNA, and protein content by flow cytometry in normal and Coxiella burnetii-infected L929 cells.
    Baca OG; Crissman HA
    Infect Immun; 1987 Jul; 55(7):1731-3. PubMed ID: 2439460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Coxiella burnetii isolates in cell culture and the expression of parasite-specific antigens on the host membrane surface.
    Roman MJ; Crissman HA; Samsonoff WA; Hechemy KE; Baca OG
    Acta Virol; 1991 Nov; 35(6):503-10. PubMed ID: 1687632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.
    Yeaman MR; Roman MJ; Baca OG
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1052-7. PubMed ID: 2782856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii.
    Akporiaye ET; Rowatt JD; Aragon AA; Baca OG
    Infect Immun; 1983 Jun; 40(3):1155-62. PubMed ID: 6852916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.
    Raoult D; Yeaman MR; Baca OG
    Antimicrob Agents Chemother; 1989 May; 33(5):621-3. PubMed ID: 2751278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling persistent host cell infection with Coxiella burnetii by quantitative proteomics.
    Vranakis I; De Bock PJ; Papadioti A; Samoilis G; Tselentis Y; Gevaert K; Tsiotis G; Psaroulaki A
    J Proteome Res; 2011 Sep; 10(9):4241-51. PubMed ID: 21790200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages.
    Voth DE; Howe D; Heinzen RA
    Infect Immun; 2007 Sep; 75(9):4263-71. PubMed ID: 17606599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of Coxiella burnetti and the pathobiochemistry of Q fever and its endotoxicosis.
    Paretsky D
    Ann N Y Acad Sci; 1990; 590():416-21. PubMed ID: 2378468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
    QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells.
    Burton PR; Stueckemann J; Welsh RM; Paretsky D
    Infect Immun; 1978 Aug; 21(2):556-66. PubMed ID: 99368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of dendritic cell maturation following infection by Coxiella burnetii synthesizing different lipopolysaccharide chemotypes.
    Shannon JG; Howe D; Heinzen RA
    Ann N Y Acad Sci; 2005 Dec; 1063():154-60. PubMed ID: 16481507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of mononuclear cells to coagulate blood in response to Coxiella burnetii.
    Miragliotta G; Fumarola D; Brezina R
    J Med Microbiol; 1989 May; 29(1):9-12. PubMed ID: 2724327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.
    Yeaman MR; Mitscher LA; Baca OG
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1079-84. PubMed ID: 3662472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic screening for possible effector molecules secreted by the obligate intracellular pathogen Coxiella burnetii.
    Samoilis G; Aivaliotis M; Vranakis I; Papadioti A; Tselentis Y; Tsiotis G; Psaroulaki A
    J Proteome Res; 2010 Mar; 9(3):1619-26. PubMed ID: 20044831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of virulence of Coxiella burnetii isolates from bovine milk and from ticks.
    Kocianová E; Kovácová EI; Literák I
    Folia Parasitol (Praha); 2001; 48(3):235-9. PubMed ID: 11699660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infection of skin fibroblasts in animals with different levels of sensitivity to Leishmania infantum and Leishmania mexicana (Kinetoplastida: Trypanosomatidae)].
    Minero MA; Chinchilla M; Guerrero OM; Castro A
    Rev Biol Trop; 2004 Mar; 52(1):261-7. PubMed ID: 17357424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.